FLEXITUBE Trademark

Trademark Overview

On Thursday, December 20, 2007, a trademark application was filed for FLEXITUBE with the United States Patent and Trademark Office. The USPTO has given the FLEXITUBE trademark a serial number of 79050248. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Tuesday, July 28, 2020. This trademark is owned by QIAGEN GmbH. The FLEXITUBE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

[ Pharmaceutical preparations for medical and veterinary purposes, namely, pharmaceutical preparations for treating tumors, autoimmune diseases, inflammatory diseases, cardiovascular diseases and diabetes; kits comprising nucleic acids, namely, nucleic acids inducing RNA interference and siRNAs, for medical veterinary diagnostic purposes ]

Chemical, biochemical and biotechnological products, all in the nature of chemicals for industrial purposes; kits comprising chemical, biochemical and biotechnological preparations, all in the nature of kits comprised primarily of multiple chemicals for use in industry; nucleic acids for laboratory use, namely, nucleic acids inducing RNA interference and siRNAs; kits comprising nucleic acids, namely, nucleic acids inducing RNA interference and siRNAs, for laboratory use for scientific and research purposes
flexitube

General Information

Serial Number79050248
Word MarkFLEXITUBE
Filing DateThursday, December 20, 2007
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateTuesday, July 28, 2020
Registration Number3778172
Registration DateTuesday, April 20, 2010
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2010

Trademark Statements

Goods and Services[ Pharmaceutical preparations for medical and veterinary purposes, namely, pharmaceutical preparations for treating tumors, autoimmune diseases, inflammatory diseases, cardiovascular diseases and diabetes; kits comprising nucleic acids, namely, nucleic acids inducing RNA interference and siRNAs, for medical veterinary diagnostic purposes ]
Pseudo MarkFLEXI TUBE
Goods and ServicesChemical, biochemical and biotechnological products, all in the nature of chemicals for industrial purposes; kits comprising chemical, biochemical and biotechnological preparations, all in the nature of kits comprised primarily of multiple chemicals for use in industry; nucleic acids for laboratory use, namely, nucleic acids inducing RNA interference and siRNAs; kits comprising nucleic acids, namely, nucleic acids inducing RNA interference and siRNAs, for laboratory use for scientific and research purposes

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, March 21, 2008
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateFriday, March 21, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQIAGEN GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHilden 40724
DE
Party NameQIAGEN GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameQIAGEN GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Thursday, March 20, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 21, 2008NEW APPLICATION ENTERED
Wednesday, March 26, 2008ASSIGNED TO EXAMINER
Friday, March 28, 2008NON-FINAL ACTION WRITTEN
Saturday, March 29, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 31, 2008REFUSAL PROCESSED BY MPU
Monday, March 31, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, April 19, 2008REFUSAL PROCESSED BY IB
Tuesday, September 30, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 30, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 30, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 16, 2008ASSIGNED TO LIE
Thursday, October 16, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 16, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 31, 2008FINAL REFUSAL WRITTEN
Friday, October 31, 2008FINAL REFUSAL E-MAILED
Friday, October 31, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 30, 2009EXPARTE APPEAL RECEIVED AT TTAB
Thursday, April 30, 2009JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, April 30, 2009EX PARTE APPEAL-INSTITUTED
Thursday, April 30, 2009TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, May 6, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 6, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 21, 2009ACTION CONTINUING FINAL - COMPLETED
Thursday, May 21, 2009ACTION DENYING REQ FOR RECON E-MAILED
Thursday, May 21, 2009NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Thursday, August 20, 2009NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, August 20, 2009NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, September 4, 2009NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, December 3, 2009JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, December 24, 2009EXAMINERS AMENDMENT -WRITTEN
Thursday, December 24, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, December 24, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 24, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, December 24, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 28, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 2, 2010PUBLISHED FOR OPPOSITION
Tuesday, February 2, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 3, 2010FINAL DISPOSITION PROCESSED
Tuesday, August 3, 2010FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 6, 2010CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, August 5, 2010CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, September 24, 2010CORRECTION TRANSACTION RECEIVED FROM IB
Monday, October 4, 2010CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Tuesday, February 5, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, December 14, 2013NEW REPRESENTATIVE AT IB RECEIVED
Thursday, March 3, 2016TEAS SECTION 71 & 15 RECEIVED
Wednesday, April 27, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 27, 2016REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Wednesday, April 27, 2016NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Thursday, January 4, 2018INTERNATIONAL REGISTRATION RENEWED
Saturday, April 20, 2019COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, March 19, 2020TEAS SECTION 71 RECEIVED
Thursday, June 4, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 28, 2020REGISTERED - PARTIAL SEC 71 ACCEPTED
Wednesday, July 29, 2020NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sunday, March 28, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, April 1, 2021INVALIDATION PROCESSED
Friday, April 2, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, May 10, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Thursday, November 20, 2025NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

flexitube acids nucleic kits namely purposes sirnas comprising interference diseases inducing